Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Tirzepatide is a synthetic peptide studied for its dual agonist activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors in controlled laboratory environments. Preclinical and experimental research has examined its receptor-binding properties and downstream signaling pathways associated with metabolic and endocrine regulatory mechanisms. Investigations in research settings focus on pathway modulation and cellular response under defined conditions. This compound is supplied strictly for laboratory research purposes only. It is not approved for human consumption, diagnostic use, or therapeutic application.
Tirzepatide is a synthetic peptide studied for its dual agonist activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors in controlled laboratory environments. Preclinical and experimental research has examined its receptor-binding properties and downstream signaling pathways associated with metabolic and endocrine regulatory mechanisms. Investigations in research settings focus on pathway modulation and cellular response under defined conditions. This compound is supplied strictly for laboratory research purposes only. It is not approved for human consumption, diagnostic use, or therapeutic application.